These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction]. Talalaenko AN Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232 [TBL] [Abstract][Full Text] [Related]
27. 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review. Olivier B; van Wijngaarden I; Soudijn W Eur Neuropsychopharmacol; 2000 Mar; 10(2):77-95. PubMed ID: 10706989 [TBL] [Abstract][Full Text] [Related]
28. Antidepressant treatment and limbic serotonergic mechanisms regulating rat locomotor activity. Plaznik A; Stefanski R; Palejko W; Bidzinski A; Kostowski W; Jessa M; Nazar M Pharmacol Biochem Behav; 1994 Jun; 48(2):315-25. PubMed ID: 8090797 [TBL] [Abstract][Full Text] [Related]
29. Some behavioral effects of microinjections of serotonin and noradrenaline into the limbic structures of the rat brain. Płaźnik A Pol J Pharmacol Pharm; 1984; 36(5):541-54. PubMed ID: 6533630 [TBL] [Abstract][Full Text] [Related]
30. Serotonergic mechanisms in the nucleus accumbens affected by chronic desipramine treatment. Płaźnik A; Stefański R; Pałejko W; Kostowski W Pharmacol Biochem Behav; 1991 May; 39(1):43-8. PubMed ID: 1833782 [TBL] [Abstract][Full Text] [Related]
31. [The agonists of I-A serotoninergic receptors restore in rats behavior impaired by L-dihydroxyphenylalanine]. Bondarenko NA; Bondarenko NA; Baran L; Klodzinska A Biull Eksp Biol Med; 1990 Dec; 110(12):627-8. PubMed ID: 2083366 [TBL] [Abstract][Full Text] [Related]
32. Serotonin and psychiatric disorders. A key to new therapeutic approaches. Costall B; Naylor RJ Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395 [TBL] [Abstract][Full Text] [Related]
33. Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists. Tadano T; Hozumi M; Satoh N; Oka R; Hishinuma T; Mizugaki M; Arai Y; Yasuhara H; Kinemuchi H; Niijima F; Nakagawasai O; Tan-no K; Kisara K Pharmacology; 2001; 62(3):157-62. PubMed ID: 11287817 [TBL] [Abstract][Full Text] [Related]
34. The pharmacology of new anxiolytics acting on 5-HT neurones. Marsden CA Postgrad Med J; 1990; 66 Suppl 2():S2-6. PubMed ID: 1975437 [TBL] [Abstract][Full Text] [Related]
36. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. McCall RB; Clement ME Pharmacol Rev; 1994 Sep; 46(3):231-43. PubMed ID: 7831380 [No Abstract] [Full Text] [Related]
38. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice. Bourin M; Hascoët M Behav Brain Res; 2010 Apr; 208(2):352-8. PubMed ID: 20006646 [TBL] [Abstract][Full Text] [Related]
39. [Recent progress in development of psychotropic drugs (1)--Anti-anxiety drugs]. Kudo Y; Kudo T Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):75-86. PubMed ID: 7796324 [TBL] [Abstract][Full Text] [Related]
40. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives]. Kostowski W; Płaźnik A Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]